{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:43:45Z","timestamp":1791413025327,"version":"4.3.3"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"DOI":"10.7759\/cureus.27278","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T08:07:46Z","timestamp":1658822866000},"source":"Crossref","is-referenced-by-count":14,"title":["Drug-Induced Hyperthermia Review"],"prefix":"10.7759","author":[{"given":"Michael","family":"Horseman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Udeani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew  S","family":"Tenpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Verduzco Jr.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja H","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Z","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nephy","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Cecile","family":"Mingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa  R","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Surani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Fever","author":"Dinarello CA","year":"2018","unstructured":"Dinarello CA, Porat R. Fever. Harrison\u2019s principles of internal medicine, 20e. Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (ed): McGraw-Hill, 2018."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2016.01.001","article-title":"Thermoregulatory disorders and illness related to heat and cold stress","volume":"196","author":"Cheshire WP Jr","year":"2016","unstructured":"Cheshire WP Jr. Thermoregulatory disorders and illness related to heat and cold stress. Auton Neurosci. 2016, 196:91-104. 10.1016\/j.autneu.2016.01.001","journal-title":"Auton Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-4087-0.00062-0","article-title":"Disorders of body temperature","volume":"120","author":"Gomez CR","year":"2014","unstructured":"Gomez CR. Disorders of body temperature. Handb Clin Neurol. 2014, 120:947-57. 10.1016\/B978-0-7020-4087-0.00062-0","journal-title":"Handb Clin Neurol"},{"key":"ref4","article-title":"5.4 Diseases, disorders, and injuries of the integumentary system","author":"Biga LM","year":"2019","unstructured":"Biga LM, Dawson S, Harwell A et al.. 5.4 Diseases, disorders, and injuries of the integumentary system. Anatomy & physiology. 2019."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0147-54-46","article-title":"Skin histology and its role in heat dissipation in three pinniped species","volume":"54","author":"Khamas WA","year":"2012","unstructured":"Khamas WA, Smodlaka H, Leach-Robinson J, Palmer L. Skin histology and its role in heat dissipation in three pinniped species. Acta Vet Scand. 2012, 54:46. 10.1186\/1751-0147-54-46","journal-title":"Acta Vet Scand"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2002.00112.x","article-title":"What is the 'true' function of skin?","volume":"11","author":"Chuong CM","year":"2002","unstructured":"Chuong CM, Nickoloff BJ, Elias PM, et al.. What is the 'true' function of skin?. Exp Dermatol. 2002, 11:159-87. 10.1034\/j.1600-0625.2002.00112.x","journal-title":"Exp Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00126.2014","article-title":"Recent advances in thermoregulation","volume":"39","author":"Tansey EA","year":"2015","unstructured":"Tansey EA, Johnson CD. Recent advances in thermoregulation. Adv Physiol Educ. 2015, 39:139-48. 10.1152\/advan.00126.2014","journal-title":"Adv Physiol Educ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/2046-7648-2-4","article-title":"Regional variations in transepidermal water loss, eccrine sweat gland density, sweat secretion rates and electrolyte composition in resting and exercising humans","volume":"2","author":"Taylor NA","year":"2013","unstructured":"Taylor NA, Machado-Moreira CA. Regional variations in transepidermal water loss, eccrine sweat gland density, sweat secretion rates and electrolyte composition in resting and exercising humans. Extrem Physiol Med. 2013, 2:4. 10.1186\/2046-7648-2-4","journal-title":"Extrem Physiol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2741\/s94","article-title":"Mechanisms and controllers of eccrine sweating in humans","volume":"2","author":"Shibasaki M","year":"2010","unstructured":"Shibasaki M, Crandall CG. Mechanisms and controllers of eccrine sweating in humans. Front Biosci (Schol Ed). 2010, 2:685-96. 10.2741\/s94","journal-title":"Front Biosci (Schol Ed)"},{"key":"ref10","article-title":"Fever versus hyperthermia","volume":"38","author":"Stitt JT","year":"1979","unstructured":"Stitt JT. Fever versus hyperthermia. Fed Proc. 1979, 38:39-43.","journal-title":"Fed Proc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2016.03.001","article-title":"Biophysical aspects of human thermoregulation during heat stress","volume":"196","author":"Cramer MN","year":"2016","unstructured":"Cramer MN, Jay O. Biophysical aspects of human thermoregulation during heat stress. Auton Neurosci. 2016, 196:3-13. 10.1016\/j.autneu.2016.03.001","journal-title":"Auton Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0885066611434000","article-title":"A case of severe heatstroke and review of pathophysiology, clinical presentation, and treatment","volume":"28","author":"Horseman MA","year":"2013","unstructured":"Horseman MA, Rather-Conally J, Saavedra C, Surani S. A case of severe heatstroke and review of pathophysiology, clinical presentation, and treatment. J Intensive Care Med. 2013, 28:334-40. 10.1177\/0885066611434000","journal-title":"J Intensive Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011089","article-title":"Heat stroke","volume":"346","author":"Bouchama A","year":"2002","unstructured":"Bouchama A, Knochel JP. Heat stroke. N Engl J Med. 2002, 346:1978-88. 10.1056\/NEJMra011089","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2009.10.003","article-title":"Thermoreceptors and thermosensitive afferents","volume":"34","author":"Schepers RJ","year":"2010","unstructured":"Schepers RJ, Ringkamp M. Thermoreceptors and thermosensitive afferents. Neurosci Biobehav Rev. 2010, 34:177-84. 10.1016\/j.neubiorev.2009.10.003","journal-title":"Neurosci Biobehav Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2015.01.010","article-title":"The molecular and cellular basis of thermosensation in mammals","volume":"34","author":"Palkar R","year":"2015","unstructured":"Palkar R, Lippoldt EK, McKemy DD. The molecular and cellular basis of thermosensation in mammals. Curr Opin Neurobiol. 2015, 34:14-9. 10.1016\/j.conb.2015.01.010","journal-title":"Curr Opin Neurobiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X113119990038","article-title":"Anoctamin 1 mediates thermal pain as a heat sensor","volume":"11","author":"Cho H","year":"2013","unstructured":"Cho H, Oh U. Anoctamin 1 mediates thermal pain as a heat sensor. Curr Neuropharmacol. 2013, 11:641-51. 10.2174\/1570159X113119990038","journal-title":"Curr Neuropharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3111","article-title":"The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons","volume":"15","author":"Cho H","year":"2012","unstructured":"Cho H, Yang YD, Lee J, et al.. The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons. Nat Neurosci. 2012, 15:1015-21. 10.1038\/nn.3111","journal-title":"Nat Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2014.04.015","article-title":"Expression of transient receptor potential vanilloid 1 and anoctamin 1 in rat trigeminal ganglion neurons innervating the tongue","volume":"106","author":"Kanazawa T","year":"2014","unstructured":"Kanazawa T, Matsumoto S. Expression of transient receptor potential vanilloid 1 and anoctamin 1 in rat trigeminal ganglion neurons innervating the tongue. Brain Res Bull. 2014, 106:17-20. 10.1016\/j.brainresbull.2014.04.015","journal-title":"Brain Res Bull"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000275537.71623.8e","article-title":"Thermoregulation: recent concepts and remaining questions","volume":"69","author":"Benarroch EE","year":"2007","unstructured":"Benarroch EE. Thermoregulation: recent concepts and remaining questions. Neurology. 2007, 69:1293-7. 10.1212\/01.wnl.0000275537.71623.8e","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1375-5","article-title":"The pathophysiological basis and consequences of fever","volume":"20","author":"Walter EJ","year":"2016","unstructured":"Walter EJ, Hanna-Jumma S, Carraretto M, Forni L. The pathophysiological basis and consequences of fever. Crit Care. 2016, 20:200. 10.1186\/s13054-016-1375-5","journal-title":"Crit Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7214.1","article-title":"Molecular chaperones: guardians of the proteome in normal and disease states","volume":"4","author":"Jeng W","year":"2015","unstructured":"Jeng W, Lee S, Sung N, Lee J, Tsai FT. Molecular chaperones: guardians of the proteome in normal and disease states. F1000Res. 2015, 4:10.12688\/f1000research.7214.1","journal-title":"F1000Res"},{"key":"ref22","article-title":"Evaluation of heat stress, heat strain, and rhabdomyolysis in park employees","author":"Eisenberg J","year":"2014","unstructured":"Eisenberg J, Methner M, National Institute for Occupational Safety and Health. Evaluation of heat stress, heat strain, and rhabdomyolysis in park employees. NIOSH Health Hazard Evaluation Report. 2014,","journal-title":"NIOSH Health Hazard Evaluation Report"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00301.2010","article-title":"Heat stroke: role of the systemic inflammatory response","volume":"109","author":"Leon LR","year":"2010","unstructured":"Leon LR, Helwig BG. Heat stroke: role of the systemic inflammatory response. J Appl Physiol (1985). 2010, 109:1980-8. 10.1152\/japplphysiol.00301.2010","journal-title":"J Appl Physiol (1985)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091442","article-title":"Neuroleptic malignant syndrome: a neuroimmunologic hypothesis","volume":"182","author":"Anglin RE","year":"2010","unstructured":"Anglin RE, Rosebush PI, Mazurek MF. Neuroleptic malignant syndrome: a neuroimmunologic hypothesis. CMAJ. 2010, 182:E834-8. 10.1503\/cmaj.091442","journal-title":"CMAJ"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1684\/abc.2009.0383","article-title":"[Increase of serum procalcitonin levels during a neuroleptic malignant syndrome]","volume":"67","author":"Cabot B","year":"2009","unstructured":"Cabot B, Pautas E, Gatey M, Perivier S, Mahieux F, Pinquier C, Hausfater P. [Increase of serum procalcitonin levels during a neuroleptic malignant syndrome]. Ann Biol Clin (Paris). 2009, 67:697-700. 10.1684\/abc.2009.0383","journal-title":"Ann Biol Clin (Paris)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23220","article-title":"Neuroleptic malignant syndrome: mechanisms, interactions, and causality","volume":"25","author":"Gillman PK","year":"2010","unstructured":"Gillman PK. Neuroleptic malignant syndrome: mechanisms, interactions, and causality. Mov Disord. 2010, 25:1780-90. 10.1002\/mds.23220","journal-title":"Mov Disord"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31817ea9c1","article-title":"Neuroleptic malignant syndrome and the acute phase response","volume":"28","author":"Rosebush PI","year":"2008","unstructured":"Rosebush PI, Anglin RE, Richards C, Mazurek MF. Neuroleptic malignant syndrome and the acute phase response. J Clin Psychopharmacol. 2008, 28:459-61. 10.1097\/JCP.0b013e31817ea9c1","journal-title":"J Clin Psychopharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.2010.02119.x","article-title":"Cardiovascular function in the heat-stressed human","volume":"199","author":"Crandall CG","year":"2010","unstructured":"Crandall CG, Gonz\u00e1lez-Alonso J. Cardiovascular function in the heat-stressed human. Acta Physiol (Oxf). 2010, 199:407-23. 10.1111\/j.1748-1716.2010.02119.x","journal-title":"Acta Physiol (Oxf)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsams.2007.07.002","article-title":"Physiological limits to exercise performance in the heat","volume":"11","author":"Hargreaves M","year":"2008","unstructured":"Hargreaves M. Physiological limits to exercise performance in the heat. J Sci Med Sport. 2008, 11:66-71. 10.1016\/j.jsams.2007.07.002","journal-title":"J Sci Med Sport"},{"key":"ref30","article-title":"Heat-related deaths--United States, 1999-2003","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","unstructured":"Centers for Disease Control and Prevention (CDC). Heat-related deaths--United States, 1999-2003. MMWR Morb Mortal Wkly Rep. 2006, 55:796-8.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1249\/01.mss.0000174895.19639.ed","article-title":"Epidemiology of hospitalizations and deaths from heat illness in soldiers","volume":"37","author":"Carter R 3rd","year":"2005","unstructured":"Carter R 3rd, Cheuvront SN, Williams JO, Kolka MA, Stephenson LA, Sawka MN, Amoroso PJ. Epidemiology of hospitalizations and deaths from heat illness in soldiers. Med Sci Sports Exerc. 2005, 37:1338-44. 10.1249\/01.mss.0000174895.19639.ed","journal-title":"Med Sci Sports Exerc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn JR","year":"2007","unstructured":"Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007, 164:870-6. 10.1176\/ajp.2007.164.6.870","journal-title":"Am J Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer379","article-title":"Gut microcirculatory and mitochondrial effects of hyperdynamic endotoxaemic shock and norepinephrine treatment","volume":"108","author":"Andersson A","year":"2012","unstructured":"Andersson A, Rundgren M, Kalman S, et al.. Gut microcirculatory and mitochondrial effects of hyperdynamic endotoxaemic shock and norepinephrine treatment. Br J Anaesth. 2012, 108:254-61. 10.1093\/bja\/aer379","journal-title":"Br J Anaesth"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/cc709","article-title":"Understanding gastrointestinal perfusion in critical care: so near, and yet so far","volume":"4","author":"Ackland G","year":"2000","unstructured":"Ackland G, Grocott MP, Mythen MG. Understanding gastrointestinal perfusion in critical care: so near, and yet so far. Crit Care. 2000, 4:269-81. 10.1186\/cc709","journal-title":"Crit Care"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/0885066612450415","article-title":"Incidence of gastric mucosal injury as measured by reactance in critically ill patients","volume":"28","author":"Beltran NE","year":"2013","unstructured":"Beltran NE, Ceron U, Sanchez-Miranda G, Remolina M, Godinez MM, Peralta IY, Sacristan E. Incidence of gastric mucosal injury as measured by reactance in critically ill patients. J Intensive Care Med. 2013, 28:230-6. 10.1177\/0885066612450415","journal-title":"J Intensive Care Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000147534.69062.dc","article-title":"Potential role of endotoxin as a proinflammatory mediator of atherosclerosis","volume":"24","author":"Stoll LL","year":"2004","unstructured":"Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004, 24:2227-36. 10.1161\/01.ATV.0000147534.69062.dc","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1086\/432000","article-title":"Lipopolysaccharide: an endotoxin or an exogenous hormone?","volume":"41","author":"Marshall JC","year":"2005","unstructured":"Marshall JC. Lipopolysaccharide: an endotoxin or an exogenous hormone?. Clin Infect Dis. 2005, 41:S470-80. 10.1086\/432000","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2012.706761","article-title":"Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities","volume":"31","author":"Moghimpour Bijani F","year":"2012","unstructured":"Moghimpour Bijani F, Vallejo JG, Rezaei N. Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities. Int Rev Immunol. 2012, 31:379-95. 10.3109\/08830185.2012.706761","journal-title":"Int Rev Immunol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1159\/000315915","article-title":"Endotoxins and other sepsis triggers","volume":"167","author":"Opal SM","year":"2010","unstructured":"Opal SM. Endotoxins and other sepsis triggers. Contrib Nephrol. 2010, 167:14-24. 10.1159\/000315915","journal-title":"Contrib Nephrol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819267fb","article-title":"Molecular biology of inflammation and sepsis: a primer","volume":"37","author":"Cinel I","year":"2009","unstructured":"Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med. 2009, 37:291-304. 10.1097\/CCM.0b013e31819267fb","journal-title":"Crit Care Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-8-4","article-title":"Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells","volume":"8","author":"Blomkalns AL","year":"2011","unstructured":"Blomkalns AL, Stoll LL, Shaheen W, Romig-Martin SA, Dickson EW, Weintraub NL, Denning GM. Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells. J Inflamm (Lond). 2011, 8:4. 10.1186\/1476-9255-8-4","journal-title":"J Inflamm (Lond)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1998.949bp.x","article-title":"Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running","volume":"508 ( Pt 3)","author":"Ostrowski K","year":"1998","unstructured":"Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol. 1998, 508 ( Pt 3):949-53. 10.1111\/j.1469-7793.1998.949bp.x","journal-title":"J Physiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2000.89.4.1499","article-title":"Exercise elevates plasma levels but not gene expression of IL-1beta, IL-6, and TNF-alpha in blood mononuclear cells","volume":"89","author":"Moldoveanu AI","year":"2000","unstructured":"Moldoveanu AI, Shephard RJ, Shek PN. Exercise elevates plasma levels but not gene expression of IL-1beta, IL-6, and TNF-alpha in blood mononuclear cells. J Appl Physiol (1985). 2000, 89:1499-504. 10.1152\/jappl.2000.89.4.1499","journal-title":"J Appl Physiol (1985)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8","author":"Gabay C","year":"2006","unstructured":"Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006, 8:S3. 10.1186\/ar1917","journal-title":"Arthritis Res Ther"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.113","article-title":"Neutrophils: interfering with intestinal inflammation","volume":"17","author":"Starling S","year":"2017","unstructured":"Starling S. Neutrophils: interfering with intestinal inflammation. Nat Rev Immunol. 2017, 17:594. 10.1038\/nri.2017.113","journal-title":"Nat Rev Immunol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1810762","article-title":"Heatstroke","volume":"380","author":"Epstein Y","year":"2019","unstructured":"Epstein Y, Yanovich R. Heatstroke. N Engl J Med. 2019, 380:2449-59. 10.1056\/NEJMra1810762","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.158709","article-title":"Microvascular injury, thrombosis, inflammation, and apoptosis in the pathogenesis of heatstroke: a study in baboon model","volume":"28","author":"Roberts GT","year":"2008","unstructured":"Roberts GT, Ghebeh H, Chishti MA, Al-Mohanna F, El-Sayed R, Al-Mohanna F, Bouchama A. Microvascular injury, thrombosis, inflammation, and apoptosis in the pathogenesis of heatstroke: a study in baboon model. Arterioscler Thromb Vasc Biol. 2008, 28:1130-6. 10.1161\/ATVBAHA.107.158709","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2013.12.015","article-title":"Plasma membranes as heat stress sensors: from lipid-controlled molecular switches to therapeutic applications","volume":"1838","author":"T\u00f6r\u00f6k Z","year":"2014","unstructured":"T\u00f6r\u00f6k Z, Crul T, Maresca B, et al.. Plasma membranes as heat stress sensors: from lipid-controlled molecular switches to therapeutic applications. Biochim Biophys Acta. 2014, 1838:1594-618. 10.1016\/j.bbamem.2013.12.015","journal-title":"Biochim Biophys Acta"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-010-0172-3","article-title":"Hsp-72, a candidate prognostic indicator of heatstroke","volume":"15","author":"Dehbi M","year":"2010","unstructured":"Dehbi M, Baturcam E, Eldali A, Ahmed M, Kwaasi A, Chishti MA, Bouchama A. Hsp-72, a candidate prognostic indicator of heatstroke. Cell Stress Chaperones. 2010, 15:593-603. 10.1007\/s12192-010-0172-3","journal-title":"Cell Stress Chaperones"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00811.2015","article-title":"Heat shock proteins and exercise adaptations. Our knowledge thus far and the road still ahead","volume":"120","author":"Henstridge DC","year":"2016","unstructured":"Henstridge DC, Febbraio MA, Hargreaves M. Heat shock proteins and exercise adaptations. Our knowledge thus far and the road still ahead. J Appl Physiol (1985). 2016, 120:683-91. 10.1152\/japplphysiol.00811.2015","journal-title":"J Appl Physiol (1985)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1992.72.4.1063","article-title":"Mammalian stress response: cell physiology, structure\/function of stress proteins, and implications for medicine and disease","volume":"72","author":"Welch WJ","year":"1992","unstructured":"Welch WJ. Mammalian stress response: cell physiology, structure\/function of stress proteins, and implications for medicine and disease. Physiol Rev. 1992, 72:1063-81. 10.1152\/physrev.1992.72.4.1063","journal-title":"Physiol Rev"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-013-0468-1","article-title":"Extracellular Hsp72 concentration relates to a minimum endogenous criteria during acute exercise-heat exposure","volume":"19","author":"Gibson OR","year":"2014","unstructured":"Gibson OR, Dennis A, Parfitt T, Taylor L, Watt PW, Maxwell NS. Extracellular Hsp72 concentration relates to a minimum endogenous criteria during acute exercise-heat exposure. Cell Stress Chaperones. 2014, 19:389-400. 10.1007\/s12192-013-0468-1","journal-title":"Cell Stress Chaperones"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000410","article-title":"HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction","volume":"8","author":"Gupta S","year":"2010","unstructured":"Gupta S, Deepti A, Deegan S, Lisbona F, Hetz C, Samali A. HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction. PLoS Biol. 2010, 8:e1000410. 10.1371\/journal.pbio.1000410","journal-title":"PLoS Biol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.427336","article-title":"Toll-like receptor agonists and febrile range hyperthermia synergize to induce heat shock protein 70 expression and extracellular release","volume":"288","author":"Gupta A","year":"2013","unstructured":"Gupta A, Cooper ZA, Tulapurkar ME, Potla R, Maity T, Hasday JD, Singh IS. Toll-like receptor agonists and febrile range hyperthermia synergize to induce heat shock protein 70 expression and extracellular release. J Biol Chem. 2013, 288:2756-66. 10.1074\/jbc.M112.427336","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.2174\/1875041901104010049","article-title":"Pediatric sepsis - part V: extracellular heat shock proteins: alarmins for the host immune system","volume":"4","author":"Giuliano JS Jr","year":"2011","unstructured":"Giuliano JS Jr, Lahni PM, Wong HR, Wheeler DS. Pediatric sepsis - part V: extracellular heat shock proteins: alarmins for the host immune system. Open Inflamm J. 2011, 4:49-60. 10.2174\/1875041901104010049","journal-title":"Open Inflamm J"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181dda0d4","article-title":"Adverse drug reactions resulting in hyperthermia in the intensive care unit","volume":"38","author":"McAllen KJ","year":"2010","unstructured":"McAllen KJ, Schwartz DR. Adverse drug reactions resulting in hyperthermia in the intensive care unit. Crit Care Med. 2010, 38:S244-52. 10.1097\/CCM.0b013e3181dda0d4","journal-title":"Crit Care Med"},{"key":"ref57","article-title":"Pathophysiology of heat-related illnesses","author":"Leon LR","year":"2012","unstructured":"Leon LR, Kenefick R, Army Research Inst of Environmental Medicine Natick MA Thermal and Mountain Medicine Division. Pathophysiology of heat-related illnesses. 2012."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2010852","article-title":"Salicylate toxicity","volume":"382","author":"Palmer BF","year":"2020","unstructured":"Palmer BF, Clegg DJ. Salicylate toxicity. N Engl J Med. 2020, 382:2544-55. 10.1056\/NEJMra2010852","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.06.022","article-title":"Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters","volume":"572","author":"Numachi Y","year":"2007","unstructured":"Numachi Y, Ohara A, Yamashita M, et al.. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol. 2007, 572:120-8. 10.1016\/j.ejphar.2007.06.022","journal-title":"Eur J Pharmacol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/cc6177","article-title":"Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity","volume":"11","author":"Eyer F","year":"2007","unstructured":"Eyer F, Zilker T. Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity. Crit Care. 2007, 11:236. 10.1186\/cc6177","journal-title":"Crit Care"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2013.07.004","article-title":"Drug-induced hyperthermic syndromes: part I. Hyperthermia in overdose","volume":"31","author":"Hayes BD","year":"2013","unstructured":"Hayes BD, Martinez JP, Barrueto F Jr. Drug-induced hyperthermic syndromes: part I. Hyperthermia in overdose. Emerg Med Clin North Am. 2013, 31:1019-33. 10.1016\/j.emc.2013.07.004","journal-title":"Emerg Med Clin North Am"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1177\/1941875210386491","article-title":"Neuroleptic malignant syndrome: a review for neurohospitalists","volume":"1","author":"Berman BD","year":"2011","unstructured":"Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists. Neurohospitalist. 2011, 1:41-7. 10.1177\/1941875210386491","journal-title":"Neurohospitalist"},{"key":"ref63","doi-asserted-by":"crossref","DOI":"10.1097\/00007611-200295080-00006","article-title":"Drug-associated heat stroke","volume":"95","author":"Martinez M","year":"2002","unstructured":"Martinez M, Devenport L, Saussy J, Martinez J. Drug-associated heat stroke. South Med J. 2002, 95:799-802.","journal-title":"South Med J"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.1.129","article-title":"Neuroleptic malignant syndrome","volume":"85","author":"Adnet P","year":"2000","unstructured":"Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth. 2000, 85:129-35. 10.1093\/bja\/85.1.129","journal-title":"Br J Anaesth"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200207000-00001","article-title":"Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?","volume":"25","author":"Gurrera RJ","year":"2002","unstructured":"Gurrera RJ. Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?. Clin Neuropharmacol. 2002, 25:183-93. 10.1097\/00002826-200207000-00001","journal-title":"Clin Neuropharmacol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2020.11.49007","article-title":"Evidence-based heatstroke management in the emergency department","volume":"22","author":"Rublee C","year":"2021","unstructured":"Rublee C, Dresser C, Giudice C, Lemery J, Sorensen C. Evidence-based heatstroke management in the emergency department. West J Emerg Med. 2021, 22:186-95. 10.5811\/westjem.2020.11.49007","journal-title":"West J Emerg Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2015.09.014","article-title":"Cooling methods in heat stroke","volume":"50","author":"Gaudio FG","year":"2016","unstructured":"Gaudio FG, Grissom CK. Cooling methods in heat stroke. J Emerg Med. 2016, 50:607-16. 10.1016\/j.jemermed.2015.09.014","journal-title":"J Emerg Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-019-0229-2","article-title":"Expert consensus on the diagnosis and treatment of heat stroke in China","volume":"7","author":"Liu SY","year":"2020","unstructured":"Liu SY, Song JC, Mao HD, Zhao JB, Song Q. Expert consensus on the diagnosis and treatment of heat stroke in China. Mil Med Res. 2020, 7:1. 10.1186\/s40779-019-0229-2","journal-title":"Mil Med Res"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00452.2019","article-title":"Controversies in exertional heat stroke diagnosis, prevention, and treatment","volume":"127","author":"Laitano O","year":"2019","unstructured":"Laitano O, Leon LR, Roberts WO, Sawka MN. Controversies in exertional heat stroke diagnosis, prevention, and treatment. J Appl Physiol (1985). 2019, 127:1338-48. 10.1152\/japplphysiol.00452.2019","journal-title":"J Appl Physiol (1985)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.626","article-title":"The efficacy of steroids in reducing morbidity and mortality from extreme hyperthermia and heatstroke-a systematic review","volume":"8","author":"Walter E","year":"2020","unstructured":"Walter E, Gibson OR. The efficacy of steroids in reducing morbidity and mortality from extreme hyperthermia and heatstroke-a systematic review. Pharmacol Res Perspect. 2020, 8:e00626. 10.1002\/prp2.626","journal-title":"Pharmacol Res Perspect"},{"key":"ref71","article-title":"Neuroleptic malignant syndrome","author":"Simon LV","year":"2022","unstructured":"Simon LV, Hashmi MF, Callahan AL. Neuroleptic malignant syndrome. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1097\/01.BCR.0000202644.17987.3F","article-title":"Neuroleptic malignant syndrome associated with metoclopramide in a burn patient","volume":"27","author":"Nachreiner R","year":"2006","unstructured":"Nachreiner R, Balledux J, Zieger M, Viegas O, Sood R. Neuroleptic malignant syndrome associated with metoclopramide in a burn patient. J Burn Care Res. 2006, 27:237-41. 10.1097\/01.BCR.0000202644.17987.3F","journal-title":"J Burn Care Res"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2019.014","article-title":"Drug-induced movement disorders","volume":"42","author":"Duma SR","year":"2019","unstructured":"Duma SR, Fung VS. Drug-induced movement disorders. Aust Prescr. 2019, 42:56-61. 10.18773\/austprescr.2019.014","journal-title":"Aust Prescr"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.116.053736","article-title":"Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association","volume":"41","author":"Sarkar S","year":"2017","unstructured":"Sarkar S, Gupta N. Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association. BJPsych Bull. 2017, 41:211-6. 10.1192\/pb.bp.116.053736","journal-title":"BJPsych Bull"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.2174\/1570159x13999150424113345","article-title":"Neuroleptic malignant syndrome: a review from a clinically oriented perspective","volume":"13","author":"Tse L","year":"2015","unstructured":"Tse L, Barr AM, Scarapicchia V, Vila-Rodriguez F. Neuroleptic malignant syndrome: a review from a clinically oriented perspective. Curr Neuropharmacol. 2015, 13:395-406. 10.2174\/1570159x13999150424113345","journal-title":"Curr Neuropharmacol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.7.2.135","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?","volume":"7","author":"Keck PE Jr","year":"1995","unstructured":"Keck PE Jr, Caroff SN, McElroy SL. Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?. J Neuropsychiatry Clin Neurosci. 1995, 7:135-44. 10.1176\/jnp.7.2.135","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref77","article-title":"Heat stroke","author":"Morris A","year":"2022","unstructured":"Morris A, Patel G. Heat stroke. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06438","article-title":"An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method","volume":"72","author":"Gurrera RJ","year":"2011","unstructured":"Gurrera RJ, Caroff SN, Cohen A, et al.. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 2011, 72:1222-8. 10.4088\/JCP.10m06438","journal-title":"J Clin Psychiatry"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson JL","year":"1985","unstructured":"Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985, 142:1137-45. 10.1176\/ajp.142.10.1137","journal-title":"Am J Psychiatry"},{"key":"ref80","article-title":"Drug treatment of the neuroleptic malignant syndrome","volume":"27","author":"Sakkas P","year":"1991","unstructured":"Sakkas P, Davis JM, Janicak PG, Wang ZY. Drug treatment of the neuroleptic malignant syndrome. Psychopharmacol Bull. 1991, 27:381-4.","journal-title":"Psychopharmacol Bull"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.149.9.1927","article-title":"Neuroleptic malignant syndrome. Review of response to therapy","volume":"149","author":"Rosenberg MR","year":"1989","unstructured":"Rosenberg MR, Green M. Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med. 1989, 149:1927-31. 10.1001\/archinte.149.9.1927","journal-title":"Arch Intern Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.159.5.709","article-title":"The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?","volume":"159","author":"Rosebush PI","year":"1991","unstructured":"Rosebush PI, Stewart T, Mazurek MF. The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?. Br J Psychiatry. 1991, 159:709-12. 10.1192\/bjp.159.5.709","journal-title":"Br J Psychiatry"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene--a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause T","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene--a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004, 59:364-73. 10.1111\/j.1365-2044.2004.03658.x","journal-title":"Anaesthesia"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jopan.2017.04.008","article-title":"Malignant hyperthermia: a review","volume":"33","author":"Mullins MF","year":"2018","unstructured":"Mullins MF. Malignant hyperthermia: a review. J Perianesth Nurs. 2018, 33:582-9. 10.1016\/j.jopan.2017.04.008","journal-title":"J Perianesth Nurs"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181a9d8d9","article-title":"The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia","volume":"109","author":"Capacchione JF","year":"2009","unstructured":"Capacchione JF, Muldoon SM. The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia. Anesth Analg. 2009, 109:1065-9. 10.1213\/ane.0b013e3181a9d8d9","journal-title":"Anesth Analg"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering","volume":"107","author":"Hopkins PM","year":"2011","unstructured":"Hopkins PM. Malignant hyperthermia: pharmacology of triggering. Br J Anaesth. 2011, 107:48-56. 10.1093\/bja\/aer132","journal-title":"Br J Anaesth"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1919622","article-title":"Malignant syndromes: current advances","volume":"20","author":"Tao M","year":"2021","unstructured":"Tao M, Li J, Wang X, Tian X. Malignant syndromes: current advances. Expert Opin Drug Saf. 2021, 20:1075-85. 10.1080\/14740338.2021.1919622","journal-title":"Expert Opin Drug Saf"},{"key":"ref88","article-title":"Malignant hyperthermia","author":"Watt S","year":"2022","unstructured":"Watt S, McAllister RK. Malignant hyperthermia. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref89","doi-asserted-by":"crossref","DOI":"10.1093\/bja\/85.1.118","article-title":"Malignant hyperthermia: advances in clinical management and diagnosis","volume":"85","author":"Hopkins PM","year":"2000","unstructured":"Hopkins PM. Malignant hyperthermia: advances in clinical management and diagnosis. Br J Anaesth. 2000, 85:118-28.","journal-title":"Br J Anaesth"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318190bb08","article-title":"Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005","volume":"110","author":"Rosero EB","year":"2009","unstructured":"Rosero EB, Adesanya AO, Timaran CH, Joshi GP. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. Anesthesiology. 2009, 110:89-94. 10.1097\/ALN.0b013e318190bb08","journal-title":"Anesthesiology"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg H","year":"2015","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015, 10:93. 10.1186\/s13023-015-0310-1","journal-title":"Orphanet J Rare Dis"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000421","article-title":"Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States","volume":"119","author":"Larach MG","year":"2014","unstructured":"Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesth Analg. 2014, 119:1359-66. 10.1213\/ANE.0000000000000421","journal-title":"Anesth Analg"},{"key":"ref93","article-title":"Dantrolene","author":"Ratto D","year":"2021","unstructured":"Ratto D, Joyner RW. Dantrolene. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer EW","year":"2005","unstructured":"Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005, 352:1112-20. 10.1056\/NEJMra041867","journal-title":"N Engl J Med"},{"key":"ref95","article-title":"Demystifying serotonin syndrome (or serotonin toxicity)","volume":"64","author":"Foong AL","year":"2018","unstructured":"Foong AL, Grindrod KA, Patel T, Kellar J. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician. 2018, 64:720-7.","journal-title":"Can Fam Physician"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.08l00690","article-title":"Serotonin syndrome associated with tramadol","volume":"11","author":"Takeshita J","year":"2009","unstructured":"Takeshita J, Litzinger MH. Serotonin syndrome associated with tramadol. Prim Care Companion J Clin Psychiatry. 2009, 11:273. 10.4088\/PCC.08l00690","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1177\/106002800303700209","article-title":"Serotonin syndrome induced by low-dose venlafaxine","volume":"37","author":"Pan JJ","year":"2003","unstructured":"Pan JJ, Shen WW. Serotonin syndrome induced by low-dose venlafaxine. Ann Pharmacother. 2003, 37:209-11. 10.1177\/106002800303700209","journal-title":"Ann Pharmacother"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.2088","article-title":"Venlafaxine- and trazodone-induced serotonin syndrome","volume":"158","author":"McCue RE","year":"2001","unstructured":"McCue RE, Joseph M. Venlafaxine- and trazodone-induced serotonin syndrome. Am J Psychiatry. 2001, 158:2088-9. 10.1176\/appi.ajp.158.12.2088","journal-title":"Am J Psychiatry"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1086\/503839","article-title":"Serotonin toxicity associated with the use of linezolid: a review of postmarketing data","volume":"42","author":"Lawrence KR","year":"2006","unstructured":"Lawrence KR, Adra M, Gillman PK. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis. 2006, 42:1578-83. 10.1086\/503839","journal-title":"Clin Infect Dis"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.76.894.254","article-title":"Venlafaxine-induced serotonin syndrome with relapse following amitriptyline","volume":"76","author":"Perry NK","year":"2000","unstructured":"Perry NK. Venlafaxine-induced serotonin syndrome with relapse following amitriptyline. Postgrad Med J. 2000, 76:254-6. 10.1136\/pmj.76.894.254","journal-title":"Postgrad Med J"},{"key":"ref101","article-title":"Serotonin syndrome","volume":"13","author":"Volpi-Abadie J","year":"2013","unstructured":"Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. 2013, 13:533-40.","journal-title":"Ochsner J"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199612000-00013","article-title":"A case of serotonin syndrome induced by concomitant treatment with low-dose trazodone and amitriptyline and lithium","volume":"11","author":"Nisijima K","year":"1996","unstructured":"Nisijima K, Shimizu M, Abe T, Ishiguro T. A case of serotonin syndrome induced by concomitant treatment with low-dose trazodone and amitriptyline and lithium. Int Clin Psychopharmacol. 1996, 11:289-90. 10.1097\/00004850-199612000-00013","journal-title":"Int Clin Psychopharmacol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092288","article-title":"The serotonin syndrome: from molecular mechanisms to clinical practice","volume":"20","author":"Francescangeli J","year":"2019","unstructured":"Francescangeli J, Karamchandani K, Powell M, Bonavia A. The serotonin syndrome: from molecular mechanisms to clinical practice. Int J Mol Sci. 2019, 20:10.3390\/ijms20092288","journal-title":"Int J Mol Sci"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1626","article-title":"Serotonin syndrome","volume":"348","author":"Buckley NA","year":"2014","unstructured":"Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014, 348:g1626. 10.1136\/bmj.g1626","journal-title":"BMJ"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.4161\/23328940.2014.985953","article-title":"The heat is on: molecular mechanisms of drug-induced hyperthermia","volume":"1","author":"Dao CK","year":"2014","unstructured":"Dao CK, Nowinski SM, Mills EM. The heat is on: molecular mechanisms of drug-induced hyperthermia. Temperature (Austin). 2014, 1:183-91. 10.4161\/23328940.2014.985953","journal-title":"Temperature (Austin)"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2013.07.003","article-title":"Hyperthermia caused by drug interactions and adverse reactions","volume":"31","author":"Paden MS","year":"2013","unstructured":"Paden MS, Franjic L, Halcomb SE. Hyperthermia caused by drug interactions and adverse reactions. Emerg Med Clin North Am. 2013, 31:1035-44. 10.1016\/j.emc.2013.07.003","journal-title":"Emerg Med Clin North Am"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2006.01.007","article-title":"Hyperthermic syndromes induced by toxins","volume":"26","author":"Rusyniak DE","year":"2006","unstructured":"Rusyniak DE, Sprague JE. Hyperthermic syndromes induced by toxins. Clin Lab Med. 2006, 26:165-84. 10.1016\/j.cll.2006.01.007","journal-title":"Clin Lab Med"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of 'ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall AP","year":"2006","unstructured":"Hall AP, Henry JA. Acute toxic effects of 'ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006, 96:678-85. 10.1093\/bja\/ael078","journal-title":"Br J Anaesth"},{"key":"ref109","article-title":"Overview of serotonin syndrome","volume":"24","author":"Iqbal MM","year":"2012","unstructured":"Iqbal MM, Basil MJ, Kaplan J, Iqbal MT. Overview of serotonin syndrome. Ann Clin Psychiatry. 2012, 24:310-8.","journal-title":"Ann Clin Psychiatry"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200007000-00001","article-title":"Serotonin syndrome. Presentation of 2 cases and review of the literature","volume":"79","author":"Mason PJ","year":"2000","unstructured":"Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore). 2000, 79:201-9. 10.1097\/00005792-200007000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1177\/026988119901300111","article-title":"The serotonin syndrome and its treatment","volume":"13","author":"Gillman PK","year":"1999","unstructured":"Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol. 1999, 13:100-9. 10.1177\/026988119901300111","journal-title":"J Psychopharmacol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410110117","article-title":"Myoclonus and ocular oscillations induced by L-tryptophan","volume":"11","author":"Baloh RW","year":"1982","unstructured":"Baloh RW, Dietz J, Spooner JW. Myoclonus and ocular oscillations induced by L-tryptophan. Ann Neurol. 1982, 11:95-7. 10.1002\/ana.410110117","journal-title":"Ann Neurol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley EJ","year":"2003","unstructured":"Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003, 96:635-42. 10.1093\/qjmed\/hcg109","journal-title":"QJM"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2007.09.007","article-title":"Serotonin syndrome: a complex but easily avoidable condition","volume":"30","author":"Dvir Y","year":"2008","unstructured":"Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry. 2008, 30:284-7. 10.1016\/j.genhosppsych.2007.09.007","journal-title":"Gen Hosp Psychiatry"},{"key":"ref115","article-title":"Serotonin syndrome","author":"Simon LV","year":"2022","unstructured":"Simon LV, Keenaghan M. Serotonin syndrome. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403612200","article-title":"Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease","volume":"279","author":"Ducreux S","year":"2004","unstructured":"Ducreux S, Zorzato F, M\u00fcller C, et al.. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J Biol Chem. 2004, 279:43838-46. 10.1074\/jbc.M403612200","journal-title":"J Biol Chem"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-008-9125-4","article-title":"The parkinsonism-hyperpyrexia syndrome","volume":"10","author":"Newman EJ","year":"2009","unstructured":"Newman EJ, Grosset DG, Kennedy PG. The parkinsonism-hyperpyrexia syndrome. Neurocrit Care. 2009, 10:136-40. 10.1007\/s12028-008-9125-4","journal-title":"Neurocrit Care"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c140017","article-title":"Heat stroke","volume":"5","author":"Leon LR","year":"2015","unstructured":"Leon LR, Bouchama A. Heat stroke. Compr Physiol. 2015, 5:611-47. 10.1002\/cphy.c140017","journal-title":"Compr Physiol"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/s0736-4679(03)00039-8","article-title":"Intrathecal baclofen withdrawal mimicking sepsis","volume":"24","author":"Kao LW","year":"2003","unstructured":"Kao LW, Amin Y, Kirk MA, Turner MS. Intrathecal baclofen withdrawal mimicking sepsis. J Emerg Med. 2003, 24:423-7. 10.1016\/s0736-4679(03)00039-8","journal-title":"J Emerg Med"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2011.112","article-title":"Management of acute overdose or withdrawal state in intrathecal baclofen therapy","volume":"50","author":"Watve SV","year":"2012","unstructured":"Watve SV, Sivan M, Raza WA, Jamil FF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord. 2012, 50:107-11. 10.1038\/sc.2011.112","journal-title":"Spinal Cord"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6904-4-6","article-title":"Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report","volume":"4","author":"Mohammed I","year":"2004","unstructured":"Mohammed I, Hussain A. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol. 2004, 4:6. 10.1186\/1472-6904-4-6","journal-title":"BMC Clin Pharmacol"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1177\/0885066613507420","article-title":"Cocaine-induced agitated delirium: a case report and review","volume":"30","author":"Plush T","year":"2015","unstructured":"Plush T, Shakespeare W, Jacobs D, Ladi L, Sethi S, Gasperino J. Cocaine-induced agitated delirium: a case report and review. J Intensive Care Med. 2015, 30:49-57. 10.1177\/0885066613507420","journal-title":"J Intensive Care Med"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2004.02.020","article-title":"Intrathecal baclofen withdrawal syndrome caused by low residual volume in the pump reservoir: a report of 2 cases","volume":"85","author":"Rigoli G","year":"2004","unstructured":"Rigoli G, Terrini G, Cordioli Z. Intrathecal baclofen withdrawal syndrome caused by low residual volume in the pump reservoir: a report of 2 cases. Arch Phys Med Rehabil. 2004, 85:2064-6. 10.1016\/j.apmr.2004.02.020","journal-title":"Arch Phys Med Rehabil"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.5414\/cn107559","article-title":"Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following \"bath salts\" injection","volume":"81","author":"Sutamtewagul G","year":"2014","unstructured":"Sutamtewagul G, Sood V, Nugent K. Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following \"bath salts\" injection. Clin Nephrol. 2014, 81:63-6. 10.5414\/cn107559","journal-title":"Clin Nephrol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.05.001","article-title":"Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia","volume":"144","author":"Matsumoto RR","year":"2014","unstructured":"Matsumoto RR, Seminerio MJ, Turner RC, Robson MJ, Nguyen L, Miller DB, O'Callaghan JP. Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia. Pharmacol Ther. 2014, 144:28-40. 10.1016\/j.pharmthera.2014.05.001","journal-title":"Pharmacol Ther"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0084-8","article-title":"Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management","volume":"27","author":"Spiller HA","year":"2013","unstructured":"Spiller HA, Hays HL, Aleguas A Jr. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management. CNS Drugs. 2013, 27:531-43. 10.1007\/s40263-013-0084-8","journal-title":"CNS Drugs"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S118438","article-title":"Neuroleptic malignant syndrome: an easily overlooked neurologic emergency","volume":"13","author":"Oruch R","year":"2017","unstructured":"Oruch R, Pryme IF, Engelsen BA, Lund A. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatr Dis Treat. 2017, 13:161-75. 10.2147\/NDT.S118438","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref128","doi-asserted-by":"crossref","DOI":"10.55460\/7NEE-ZX24","article-title":"Review, clinical update, and practice guidelines for excited delirium syndrome","volume":"15","author":"Gerold KB","year":"2015","unstructured":"Gerold KB, Gibbons ME, Fisette RE Jr, Alves D. Review, clinical update, and practice guidelines for excited delirium syndrome. J Spec Oper Med. 2015, 15:62-9.","journal-title":"J Spec Oper Med"},{"key":"ref129","article-title":"Neuroleptic agent toxicity","author":"Boushra M","year":"2021","unstructured":"Boushra M, Nagalli S. Neuroleptic agent toxicity. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.9.6318","article-title":"Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism","volume":"179","author":"Chase MA","year":"2007","unstructured":"Chase MA, Wheeler DS, Lierl KM, Hughes VS, Wong HR, Page K. Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism. J Immunol. 2007, 179:6318-24. 10.4049\/jimmunol.179.9.6318","journal-title":"J Immunol"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0905523","article-title":"Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72","volume":"79","author":"Johnson JD","year":"2006","unstructured":"Johnson JD, Fleshner M. Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72. J Leukoc Biol. 2006, 79:425-34. 10.1189\/jlb.0905523","journal-title":"J Leukoc Biol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118010","article-title":"Bacterial lipopolysaccharide augments febrile-range hyperthermia-induced heat shock protein 70 expression and extracellular release in human THP1 cells","volume":"10","author":"Tulapurkar ME","year":"2015","unstructured":"Tulapurkar ME, Ramarathnam A, Hasday JD, Singh IS. Bacterial lipopolysaccharide augments febrile-range hyperthermia-induced heat shock protein 70 expression and extracellular release in human THP1 cells. PLoS One. 2015, 10:e0118010. 10.1371\/journal.pone.0118010","journal-title":"PLoS One"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.2174\/157339506778018514","article-title":"Initiation of the immune response by extracellular Hsp72: chaperokine activity of Hsp72","volume":"2","author":"Asea A","year":"2006","unstructured":"Asea A. Initiation of the immune response by extracellular Hsp72: chaperokine activity of Hsp72. Curr Immunol Rev. 2006, 2:209-15. 10.2174\/157339506778018514","journal-title":"Curr Immunol Rev"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00433.x","article-title":"Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target","volume":"159","author":"Becker KL","year":"2010","unstructured":"Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol. 2010, 159:253-64. 10.1111\/j.1476-5381.2009.00433.x","journal-title":"Br J Pharmacol"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021444","article-title":"Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors","volume":"89","author":"Becker KL","year":"2004","unstructured":"Becker KL, Nyl\u00e9n ES, White JC, M\u00fcller B, Snider RH Jr. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004, 89:1512-25. 10.1210\/jc.2002-021444","journal-title":"J Clin Endocrinol Metab"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.39367","article-title":"Procalcitonin: a promising tool or just another overhyped test?","volume":"17","author":"Paudel R","year":"2020","unstructured":"Paudel R, Dogra P, Montgomery-Yates AA, Coz Yataco A. Procalcitonin: a promising tool or just another overhyped test?. Int J Med Sci. 2020, 17:332-7. 10.7150\/ijms.39367","journal-title":"Int J Med Sci"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1993.tb07526.x","article-title":"Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place?","volume":"48","author":"Watson JD","year":"1993","unstructured":"Watson JD, Ferguson C, Hinds CJ, Skinner R, Coakley JH. Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place?. Anaesthesia. 1993, 48:1057-60. 10.1111\/j.1365-2044.1993.tb07526.x","journal-title":"Anaesthesia"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-16104-4","article-title":"The impact of food bioactives on health: in vitro and ex vivo models","author":"Verhoeckx K","year":"2015","unstructured":"Verhoeckx K, Cotter P, L\u00f3pez-Exp\u00f3sito I, et al.. The impact of food bioactives on health: in vitro and ex vivo models. Springer, Cham, Switzerland; 2015. 10.1007\/978-3-319-16104-4"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073571","article-title":"Eicosapentaenoic acid enhances heat stress-impaired intestinal epithelial barrier function in Caco-2 cells","volume":"8","author":"Xiao G","year":"2013","unstructured":"Xiao G, Tang L, Yuan F, et al.. Eicosapentaenoic acid enhances heat stress-impaired intestinal epithelial barrier function in Caco-2 cells. PLoS One. 2013, 8:e73571. 10.1371\/journal.pone.0073571","journal-title":"PLoS One"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00401.2005","article-title":"Physiologically relevant increase in temperature causes an increase in intestinal epithelial tight junction permeability","volume":"290","author":"Dokladny K","year":"2006","unstructured":"Dokladny K, Moseley PL, Ma TY. Physiologically relevant increase in temperature causes an increase in intestinal epithelial tight junction permeability. Am J Physiol Gastrointest Liver Physiol. 2006, 290:G204-12. 10.1152\/ajpgi.00401.2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.070522","article-title":"Cellular and molecular mechanisms of heat stress-induced up-regulation of occludin protein expression: regulatory role of heat shock factor-1","volume":"172","author":"Dokladny K","year":"2008","unstructured":"Dokladny K, Ye D, Kennedy JC, Moseley PL, Ma TY. Cellular and molecular mechanisms of heat stress-induced up-regulation of occludin protein expression: regulatory role of heat shock factor-1. Am J Pathol. 2008, 172:659-70. 10.2353\/ajpath.2008.070522","journal-title":"Am J Pathol"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00536.2015","article-title":"Intestinal epithelial barrier function and tight junction proteins with heat and exercise","volume":"120","author":"Dokladny K","year":"2016","unstructured":"Dokladny K, Zuhl MN, Moseley PL. Intestinal epithelial barrier function and tight junction proteins with heat and exercise. J Appl Physiol (1985). 2016, 120:692-701. 10.1152\/japplphysiol.00536.2015","journal-title":"J Appl Physiol (1985)"},{"key":"ref143","article-title":"Methamphetamine-associated shock with intestinal infarction","volume":"6","author":"Brannan TA","year":"2004","unstructured":"Brannan TA, Soundararajan S, Houghton BL. Methamphetamine-associated shock with intestinal infarction. MedGenMed. 2004, 6:6.","journal-title":"MedGenMed"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199112000-00015","article-title":"Methamphetamine-induced ischemic colitis","volume":"13","author":"Johnson TD","year":"1991","unstructured":"Johnson TD, Berenson MM. Methamphetamine-induced ischemic colitis. J Clin Gastroenterol. 1991, 13:687-9. 10.1097\/00004836-199112000-00015","journal-title":"J Clin Gastroenterol"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2009.139","article-title":"Methamphetamine colitis: a rare case of ischemic colitis in a young patient","volume":"144","author":"Holubar SD","year":"2009","unstructured":"Holubar SD, Hassinger JP, Dozois EJ, Masuoka HC. Methamphetamine colitis: a rare case of ischemic colitis in a young patient. Arch Surg. 2009, 144:780-2. 10.1001\/archsurg.2009.139","journal-title":"Arch Surg"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01260.x","article-title":"Pharmacologically mediated colon ischemia","volume":"102","author":"Hass DJ","year":"2007","unstructured":"Hass DJ, Kozuch P, Brandt LJ. Pharmacologically mediated colon ischemia. Am J Gastroenterol. 2007, 102:1765-80. 10.1111\/j.1572-0241.2007.01260.x","journal-title":"Am J Gastroenterol"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30192.x","article-title":"Colonic toxicity of administered drugs and chemicals","volume":"99","author":"Cappell MS","year":"2004","unstructured":"Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004, 99:1175-90. 10.1111\/j.1572-0241.2004.30192.x","journal-title":"Am J Gastroenterol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48428-2","article-title":"Cocaine induces inflammatory gut milieu by compromising the mucosal barrier integrity and altering the gut microbiota colonization","volume":"9","author":"Chivero ET","year":"2019","unstructured":"Chivero ET, Ahmad R, Thangaraj A, et al.. Cocaine induces inflammatory gut milieu by compromising the mucosal barrier integrity and altering the gut microbiota colonization. Sci Rep. 2019, 9:12187. 10.1038\/s41598-019-48428-2","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102411-drug-induced-hyperthermia-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:36:34Z","timestamp":1707489394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102411-drug-induced-hyperthermia-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":148,"URL":"https:\/\/doi.org\/10.7759\/cureus.27278","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,26]]}}}